跳至主要内容
临床试验/NCT03123562
NCT03123562已完成2 期

Improvement in Gross Motor Function and Muscle Tone in Children With Cerebral Palsy Related to Neonatal Icterus: An Open-label, Uncontrolled Clinical Trial

Vinmec Research Institute of Stem Cell and Gene Technology2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2014年4月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
25
试验地点
2
主要终点
GMFM-88 and GMFM-66 Percentile

研究概览

简要总结

The purpose of this study is to evaluate the safety and effectiveness of stem cells for cerebral palsy related to neonatal icterus

详细描述

The purpose of this study is to evaluate the safety and effectiveness of autologous bone marrow mononuclear stem cells in 25 patients with cerebral palsy related to neonatal icterus at Vinmec International Hospital, Hanoi, Vietnam

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

盲法说明

Open Label

入排标准

年龄范围
1 Year 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Cerebral palsy of any types caused by neonatal icterus

排除标准

  • Hydrocephalus with ventricular drain
  • Coagulation disorders
  • Allergy to anesthetic agents
  • Severe health conditions such as cancer, failure of heart, lung, liver or kidney
  • Active infections

研究组 & 干预措施

Stem cell transplantation

Experimental

Stem cell transplantation 2 intrathecal administrations of autologous bone marrow mononuclear cells at baseline and 6 months afterward

干预措施: Stem cell transplantation (Combination Product)

结局指标

主要结局

GMFM-88 and GMFM-66 Percentile

时间窗: Time Frame: Baseline and 6 months after transplantation

Change in Total Score of Gross Motor Function Measure GMFM-88 and GMFM-66 Percentile

次要结局

  • Number of adverse events(Through study completion, an average of 6 months)
  • Change in Muscle tone(Time Frame: Baseline and 6 months after transplantation)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验